Back to Search Start Over

Hypertensive Crisis in a Pediatric Patient Experiencing Clonidine Withdrawal

Authors :
Can Cao
Matthew L. Lorenz
Phillip Sojka
Allison W. Brindle
Lisa Swartz Topor
Source :
Case Reports in Pediatrics, Vol 2022 (2022)
Publication Year :
2022
Publisher :
Hindawi Limited, 2022.

Abstract

Background. Clonidine, a central alpha-adrenoreceptor agonist, was initially developed as an antihypertensive. Though no longer commonly used for its original indication due to rebound hypertension after discontinuation, it is currently widely prescribed as a treatment for many pediatric indications including sleep disorders, behavioral concerns, and attention deficit hyperactivity disorder. Case Report. We describe a girl who developed prolonged symptoms of clonidine withdrawal, including hypertension and elevated serum metanephrines. Discussion. Clonidine withdrawal in pediatric patient can present with hypertensive urgency and other signs of sympathetic stimulation. Withdrawal can also lead to dramatic elevation in serum metanephrines. Treatment with a clonidine taper will reduce development of withdrawal symptoms. Conclusion. Given the rise in clonidine use in pediatric patients, clinicians should be aware of the risk of clonidine withdrawal and how to recognize and avoid its development.

Subjects

Subjects :
Pediatrics
RJ1-570

Details

Language :
English
ISSN :
20906811
Volume :
2022
Database :
Directory of Open Access Journals
Journal :
Case Reports in Pediatrics
Publication Type :
Academic Journal
Accession number :
edsdoj.76f6c7e1f38f403b823e49b3d0d4a853
Document Type :
article
Full Text :
https://doi.org/10.1155/2022/9005063